CCNB1
MOLECULAR TARGETcyclin B1
CCNB1 (cyclin B1) is targeted by 8 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting CCNB1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | azd 5438 | 2.71 | 14 |
| 2 | kenpaullone | 2.56 | 12 |
| 3 | alsterpaullone | 1.79 | 5 |
| 4 | indirubin | 1.39 | 3 |
| 5 | Apigenin 5,7,4'-trihydroxy-flavone, | 0.69 | 1 |
| 6 | chrysin | 0.69 | 1 |
| 7 | fisetin | 0.69 | 1 |
| 8 | Luteolin 5,7,3',4'-tetrahydroxy-flavone, | 0.69 | 1 |
About CCNB1 as a Drug Target
CCNB1 (cyclin B1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 8 compounds with documented CCNB1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
CCNB1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.